IL6 and neoplasm: In our study, notably, blocking IL-6 signaling with intravenous injections of IL-6 neutralizing antibodies suppressed xenograft tumor growth, suggesting that IL-6 signaling would be therapeutic target for inhibiting early stage breast tumor progression.